NCT02415881 - Panitumumab IRDye800 Optical Imaging Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

November 23, 2019

Study Completion Date

September 21, 2021

Conditions

Head and Neck Cancer

Interventions

DRUG

Panitumumab IRDye 800

Patients will receive Panitumumab IRDye 800 prior to their scheduled surgery

DEVICE

da Vinci Firefly

Da Vinci surgical robot with build-in fluorescence imaging option (Firefly technology)

DEVICE

IMAGE1 + ICG Hopkins telescope and/or VITOM

IMAGE1 + ICG Hopkins telescope and/or VITOM -- Fluorescence camera allowing for imaging of IRDye800. Camera is suitable for open and laparoscopic surgery.

Trial Locations (2)

35294

University of Alabama at Birmingham Cancer Center, Birmingham

94305

Stanford University, School of Medicine, Stanford

All Listed Sponsors

lead

Eben Rosenthal

OTHER